Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

25.00
-0.5000-1.96%
Post-market: 25.220.2188+0.88%19:56 EDT
Volume:204.05K
Turnover:5.09M
Market Cap:171.35M
PE:-0.07
High:25.56
Open:25.16
Low:24.59
Close:25.50
52wk High:65.80
52wk Low:2.62
Shares:6.85M
Float Shares:3.18M
Volume Ratio:0.45
T/O Rate:6.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-342.6591
EPS(LYR):-34.0333
ROE:-125.43%
ROA:-121.29%
PB:-0.11
PE(LYR):-0.73

Loading ...

Jul 15, 2025

Proposed Sale Of Securities

Form 144 | VOR BIOPHARMA INC.'s Officer Robert Ang proposes to sell 214135 Shares, with a total value of approximately $520,586.
Jul 10, 2025

Major Issues Report

Form 8-K - Current report
Jul 10, 2025

Proposed Sale Of Securities

Form 144 | VOR BIOPHARMA INC. Officer Robert Ang proposes to sell 596,885 shares, with a total value of approximately $1.39 million.
Jul 03, 2025

Proposed Sale Of Securities

Form 144 | VOR BIOPHARMA's Officer Robert Ang proposes to sell 44,936 Shares, with a total value of approximately $80,435.
Jul 01, 2025

Proposed Sale Of Securities

Form 144 | VOR BIOPHARMA Officer Robert Ang proposes to sell 40468 shares, with a total value of approximately $69613.
Jun 30, 2025

Proposed Sale Of Securities

Form 144 | VOR BIOPHARMA INC.'s Officer Robert Ang proposes to sell 40,627 shares, with a total value of approximately $70,289.
Jun 26, 2025

Major Issues Report

Form 8-K - Current report
May 23, 2025

Major Issues Report

Form 8-K - Current report
May 21, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Apr 25, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2025

Major Issues Report

Form 8-K - Current report
Mar 28, 2025

Correspondence

Form CORRESP - Correspondence
Mar 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Jan 28, 2025

Correspondence

Form CORRESP - Correspondence